Pierre Demoyen

Pierre Demoyen serves as CEO at Invectys. Invectys operates in the biotechnology sector with approximately 22.0 employees. The company is headquartered in Paris, Ile-de-France. Invectys generates annual revenue of 4200000.0. To date, Invectys has raised 54454879.0 in total funding, with the most recent round being Debt Financing.

Industry & Role Insights

• • MessageCEO tracks 381 executives in the biotechnology sector.
• • 4,101 executive contacts are available in Ile-de-France.
• • Our database includes 201,465 c suite-level executives.

Outlook Microsoft Office 365 Google Analytics WordPress.org Mobile Friendly Google Font API reCAPTCHA Remote Sisense Domo KNIME Splunk

oncology immunotherapy biotech cancer immunotherapy anti-cancer therapies hla-g platform ivs-3001 car t cells immune checkpoint tumor-specific antigens telomerase hla-g antigen biopharmaceuticals clinical trials immunologic responses therapeutic approaches fda fast track solid tumors unmet medical needs research & innovation targeted cancer treatment novel therapies cellular therapies immune system modulation tumor growth inhibition cancer treatment pipeline combination therapy clinical development personalized medicine patient-centered care biotech collaborations natural immune response fda clearance monoclonal antibodies immune system restoration research grants hla-g research investor support biological drug development cell therapy advancements metastatic melanoma antitumor immunology therapeutic vaccines patient safety clinical efficacy clinical research biotech investment advanced cancer therapies novel treatment paradigms peer-reviewed publications scientific advisory board manufacturing capabilities hospital & health care health care health wellness & fitness

CB

Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio

JL

Jason Loveridge CEO at 4SC AG

MM

Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant

JR

Julie Rubinstein President and Chief Operating Officer at Adaptive Biotechnologies Corp.

CH

Chris Harano President and CEO at Advanced BioCatalytics

Outreach Guidance — biotechnology Sector

Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Pierre Demoyen, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.

Pierre Demoyen's Position in the MessageCEO Database

• •Pierre Demoyen is 1 of 1 verified executive contact we track at Invectys.
• •365 verified executive contacts in biotechnology are in the MessageCEO database.
• •4,045 verified executive contacts in Ile-de-France are in the database.
• •18 verified contacts work at biotechnology companies in the 22.0 employee range (same size as Invectys).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated October 2026.

How do I reach Pierre Demoyen directly?

Pierre Demoyen's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Invectys. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Pierre Demoyen work for?

Pierre Demoyen is CEO at Invectys, a company in the biotechnology sector with 22.0 employees. The company is based in Paris, Ile-de-France.

Can I pitch or sell to Pierre Demoyen?

As CEO at Invectys, Pierre Demoyen is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Pierre Demoyen directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Pierre Demoyen in?

Pierre Demoyen works in the biotechnology industry as CEO at Invectys. MessageCEO provides verified contact information for executives across all major industries.

Is Pierre Demoyen's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Pierre Demoyen's profile is kept up-to-date with the latest available information.

Last updated: October 30, 2026